Literature DB >> 15605289

Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut.

Michel de Groot1, Antoi P W Meeuwis, Peter J M Kok, Frans H M Corstens, Wim J G Oyen.   

Abstract

PURPOSE: Increased, non-pathological FDG uptake in myocardium, stomach and bowel is frequently observed while performing clinical positron emission tomography (PET) studies. This "physiological" increased FDG uptake is not related to (oncological) disease and is unwanted since it may interfere with correct image reading. We evaluated the role of several patient-related factors that may have an influence on this phenomenon.
METHODS: One hundred and seventy-five non-diabetic patients with malignant diseases, referred to our department for routine whole-body FDG-PET, were retrospectively evaluated. Age, blood glucose levels and duration of the fasting period were recorded. FDG uptake in myocardium, bowel and stomach was visually graded.
RESULTS: Statistical analysis showed that increased FDG uptake in myocardium, bowel and stomach was not significantly correlated to blood glucose level, age or duration of fasting. Most patients who underwent repeated PET scans (92 scans in 25 patients), showed no or minor changes in uptake in bowel and stomach on the consecutive scans, while myocardial uptake was more variable.
CONCLUSION: Age, fasting period and blood glucose levels did not influence physiological uptake. However, there seemed to be a patient-specific pattern for stomach and bowel uptake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15605289     DOI: 10.1007/s00259-004-1670-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  4 in total

1.  Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations.

Authors:  H Engel; H Steinert; A Buck; T Berthold; R A Huch Böni; G K von Schulthess
Journal:  J Nucl Med       Date:  1996-03       Impact factor: 10.057

Review 2.  Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation.

Authors:  G J Cook; I Fogelman; M N Maisey
Journal:  Semin Nucl Med       Date:  1996-10       Impact factor: 4.446

Review 3.  Limitations of PET for imaging lymphoma.

Authors:  Sally F Barrington; Michael J O'Doherty
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-13       Impact factor: 9.236

4.  Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region.

Authors:  Thomas F Hany; Esmaiel Gharehpapagh; Ehab M Kamel; Alfred Buck; Jean Himms-Hagen; Gustav K von Schulthess
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-08-08       Impact factor: 9.236

  4 in total
  40 in total

Review 1.  Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.

Authors:  Ian S Rogers; Ahmed Tawakol
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

2.  Myo-Myo: Yes, papa. Eating sugar? No, papa! Modulating the myocardial menu for imaging coronary inflammation...

Authors:  Jagat Narula; H William Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11       Impact factor: 9.236

3.  Suppression of myocardial 18F-FDG uptake with a preparatory "Atkins-style" low-carbohydrate diet.

Authors:  Richard Coulden; Peter Chung; Emer Sonnex; Quazi Ibrahim; Conor Maguire; Jon Abele
Journal:  Eur Radiol       Date:  2012-05-18       Impact factor: 5.315

Review 4.  18F-FDG-PET/CT Imaging to Diagnose Septic Emboli and Mycotic Aneurysms in Patients with Endocarditis and Cardiac Device Infections.

Authors:  Nidaa Mikail; Khadija Benali; Besma Mahida; Jonathan Vigne; Fabien Hyafil; François Rouzet; Dominique Le Guludec
Journal:  Curr Cardiol Rep       Date:  2018-03-06       Impact factor: 2.931

5.  Pretreatment with diphenoxylate hydrochloride/atropine sulfate (Lomotil) does not decrease physiologic bowel FDG activity on PET/CT scans of the abdomen and pelvis.

Authors:  Robert Murphy; Kirk M Doerger; Mark A Nathan; Val J Lowe
Journal:  Mol Imaging Biol       Date:  2008-11-27       Impact factor: 3.488

6.  A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin.

Authors:  Chantal P Bleeker-Rovers; Fidel J Vos; Aart H Mudde; Anton S M Dofferhoff; Lioe-Fee de Geus-Oei; Anton J Rijnders; Paul F M Krabbe; Frans H M Corstens; Jos W M van der Meer; Wim J G Oyen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-14       Impact factor: 9.236

7.  Unexpected FDG-PET uptake in the gastrointestinal tract: endoscopic and histopathological correlations.

Authors:  Eran Goldin; Mahmud Mahamid; Benjamin Koslowsky; Shimon Shteingart; Yael Dubner; Gadi Lalazar; Dov Wengrower
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

8.  Noninvasive Positron Emission Tomography Imaging of Coronary Arterial Inflammation.

Authors:  Amr Abdelbaky; Ahmed Tawakol
Journal:  Curr Cardiovasc Imaging Rep       Date:  2011-02-01

9.  Comparison of myocardial F-18 FDG uptake between overnight and non-overnight fasting in non-diabetic healthy subjects.

Authors:  Hyo Young Lee; Hyun-Yeol Nam; Seong Kyu Shin
Journal:  Jpn J Radiol       Date:  2015-05-16       Impact factor: 2.374

10.  Focal mass-like cardiac uptake on oncologic FDG PET/CT: Real lesion or atypical pattern of physiologic uptake?

Authors:  Yiyan Liu
Journal:  J Nucl Cardiol       Date:  2018-11-15       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.